The Flowr Corporation Share Price

Equities

FLWPF

CA34354X1087

Pharmaceuticals

Market Closed - OTC Markets 20:47:13 08/05/2024 BST 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for The Flowr Corporation 0.00% -99.00%
Sales 2020 7.51 593.23 Sales 2021 12.35 975 Capitalization 22.37M 1.77B
Net income 2020 -126M -9.95B Net income 2021 -85M -6.71B EV / Sales 2020 16,546,858 x
Net Debt 2020 29.2M 2.31B Net Debt 2021 17.1M 1.35B EV / Sales 2021 3,196,178 x
P/E ratio 2020
-0.35 x
P/E ratio 2021
-0.24 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 65.85%
More Fundamentals * Assessed data
Dynamic Chart
1 month
0.00
Extreme 0
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.28
5 years
0.00
Extreme 0
5.78
10 years
0.00
Extreme 0
6.30
More quotes
Date Price Change Volume

Delayed Quote OTC Markets, May 08, 2024 at 08:47 pm

More quotes
The Flowr Corporation is a Canada-based cannabis company. The principal activity of the Company is the production and sale of premium cannabis in Canada, and medical cannabis products in other legal global markets, primarily Portugal and the European Union. It is focused on producing, marketing, and distributing dried cannabis flower products, such as packaged dried cannabis flower and pre-rolls, and intends to offer product formats such as cannabis oils, vape technology, edibles, beverages and topical products. The Company primarily operates through two segments: Flowr Canada, which is a licensed producer operating in Canada, and Holigen, which is a licensed producer with operations primarily in Portugal. Its brands include Flowr and FlowrRX. Its subsidiaries include The Flowr Canada Holdings ULC, Holigen Holdings Limited, Holigen Limited, The Flowr Group (Okanagan) Inc., RPK Biopharma Unipessoal Lda, TCann Pty Ltd and GreyCan Pty Ltd.
More about the company

Quarterly revenue - Rate of surprise